- Home
- EMA vs MEDP Comparison
EMA vs MEDP Comparison
Compare EMA & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMA
- MEDP
- Stock Information
- Founded
- EMA 1998
- MEDP 1992
- Country
- EMA Canada
- MEDP United States
- Employees
- EMA N/A
- MEDP N/A
- Industry
- EMA Electric Utilities: Central
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- EMA Utilities
- MEDP Health Care
- Exchange
- EMA Nasdaq
- MEDP Nasdaq
- Market Cap
- EMA 14.3B
- MEDP 13.4B
- IPO Year
- EMA N/A
- MEDP 2016
- Fundamental
- Price
- EMA $47.98
- MEDP $593.52
- Analyst Decision
- EMA
- MEDP Hold
- Analyst Count
- EMA 0
- MEDP 12
- Target Price
- EMA N/A
- MEDP $465.18
- AVG Volume (30 Days)
- EMA 160.4K
- MEDP 330.7K
- Earning Date
- EMA 11-07-2025
- MEDP 10-22-2025
- Dividend Yield
- EMA 4.34%
- MEDP N/A
- EPS Growth
- EMA 67.89
- MEDP 25.36
- EPS
- EMA 2.65
- MEDP 14.32
- Revenue
- EMA $6,126,111,896.00
- MEDP $2,358,373,000.00
- Revenue This Year
- EMA $22.22
- MEDP $21.48
- Revenue Next Year
- EMA N/A
- MEDP $11.90
- P/E Ratio
- EMA $18.24
- MEDP $41.21
- Revenue Growth
- EMA 15.17
- MEDP 13.88
- 52 Week Low
- EMA $43.90
- MEDP $250.05
- 52 Week High
- EMA $49.77
- MEDP $625.00
- Technical
- Relative Strength Index (RSI)
- EMA 48.40
- MEDP 61.33
- Support Level
- EMA $47.37
- MEDP $573.07
- Resistance Level
- EMA $48.61
- MEDP $609.13
- Average True Range (ATR)
- EMA 0.64
- MEDP 17.50
- MACD
- EMA -0.05
- MEDP -2.71
- Stochastic Oscillator
- EMA 46.73
- MEDP 55.78
About EMA Emera Incorporated Common Shares
Emera is a geographically diverse energy and services company investing in electricity generation, transmission, and distribution as well as gas transmission and utility energy services. Emera has operations throughout North America and the Caribbean countries.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.